Our groundbreaking Plasma-based Bioactive Materials (PBM) are designed to improve
patient outcomes and thereby potentially reduce healthcare costs across a variety of clinical settings
Currently engaged in HEAL II pivotal study designed to show Healing Enhance & Accelerated in Long bone fracture
Currently engaged in ongoing pre-clinical studies designed to test for benefits of chronic wound healing
Our dedicated team has a passion for making a difference in the lives of patients. We are developing multiple transformational PBM products to address unmet clinical needs.
Our patented Plasma-based Bioactive Materials (PBMs) promote healing.
Our PBMs contain a wide array of growth factors found in platelet-enriched plasma from allogeneic sources.
A First-In-Human (FIH) clinical trial was successfully completed on the use of the Bone Healing Accelerant to treat open tibia fractures (trauma).